Sheth AN - Search Results

1

Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection.

Titanji K, Vunnava A, Sheth AN, Delille C, Lennox JL, Sanford SE, Foster A, Knezevic A, Easley KA, Weitzmann MN, Ofotokun I. Titanji K, et al. Among authors: sheth an. PLoS Pathog. 2014 Nov 13;10(10):e1004497. doi: 10.1371/journal.ppat.1004497. eCollection 2014 Oct. PLoS Pathog. 2014. PMID: 25393853 Free PMC article.

2

High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States.

Hochberg NS, Moro RN, Sheth AN, Montgomery SP, Steurer F, McAuliffe IT, Wang YF, Armstrong W, Rivera HN, Lennox JL, Franco-Paredes C. Hochberg NS, et al. Among authors: sheth an. PLoS Negl Trop Dis. 2011 Apr 12;5(4):e1034. doi: 10.1371/journal.pntd.0001034. PLoS Negl Trop Dis. 2011. PMID: 21532747 Free PMC article.

3

A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot randomized trial to assess efficacy and safety profile: the KITE study.

Ofotokun I, Sheth AN, Sanford SE, Easley KA, Shenvi N, White K, Eaton ME, Del Rio C, Lennox JL. Ofotokun I, et al. Among authors: sheth an. AIDS Res Hum Retroviruses. 2012 Oct;28(10):1196-206. doi: 10.1089/AID.2011.0336. Epub 2012 Apr 20. AIDS Res Hum Retroviruses. 2012. PMID: 22364141 Free PMC article. Clinical Trial.

4

Integrated population pharmacokinetic/viral dynamic modelling of lopinavir/ritonavir in HIV-1 treatment-naïve patients.

Wang K, D'Argenio DZ, Acosta EP, Sheth AN, Delille C, Lennox JL, Kerstner-Wood C, Ofotokun I. Wang K, et al. Among authors: sheth an. Clin Pharmacokinet. 2014 Apr;53(4):361-71. doi: 10.1007/s40262-013-0122-1. Clin Pharmacokinet. 2014. PMID: 24311282 Free PMC article.

5

HIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle.

Sheth AN, Evans-Strickfaden T, Haaland R, Martin A, Gatcliffe C, Adesoye A, Omondi MW, Lupo LD, Danavall D, Easley K, Chen CY, Pau CP, Hart C, Ofotokun I. Sheth AN, et al. J Infect Dis. 2014 Sep 1;210(5):736-44. doi: 10.1093/infdis/jiu166. Epub 2014 Mar 18. J Infect Dis. 2014. PMID: 24643223 Free PMC article.

6

Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations.

Delille CA, Pruett ST, Marconi VC, Lennox JL, Armstrong WS, Arrendale RF, Sheth AN, Easley KA, Acosta EP, Vunnava A, Ofotokun I. Delille CA, et al. Among authors: sheth an. J Clin Pharmacol. 2014 Sep;54(9):1063-71. doi: 10.1002/jcph.298. Epub 2014 Apr 8. J Clin Pharmacol. 2014. PMID: 24691856 Free PMC article. Clinical Trial.

7

Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patients.

Lahiri CD, Tao S, Jiang Y, Sheth AN, Acosta EP, Marconi VC, Armstrong WS, Schinazi RF, Vunnava A, Sanford S, Ofotokun I. Lahiri CD, et al. Among authors: sheth an. AIDS. 2015 Jun 1;29(9):1113-5. doi: 10.1097/QAD.0000000000000659. AIDS. 2015. PMID: 25870991 Free PMC article.

8

Cerebrospinal fluid concentrations of tenofovir and emtricitabine in the setting of HIV-1 protease inhibitor-based regimens.

Lahiri CD, Reed-Walker K, Sheth AN, Acosta EP, Vunnava A, Ofotokun I. Lahiri CD, et al. Among authors: sheth an. J Clin Pharmacol. 2016 Apr;56(4):492-6. doi: 10.1002/jcph.612. Epub 2015 Oct 20. J Clin Pharmacol. 2016. PMID: 26247878 Free PMC article. No abstract available.

9

Antiretroviral Regimen Durability and Success in Treatment-Naive and Treatment-Experienced Patients by Year of Treatment Initiation, United States, 1996-2011.

Sheth AN, Ofotokun I, Buchacz K, Armon C, Chmiel JS, Hart RL, Baker R, Brooks JT, Palella FJ Jr. Sheth AN, et al. J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):47-56. doi: 10.1097/QAI.0000000000000813. J Acquir Immune Defic Syndr. 2016. PMID: 26334737 Free PMC article.

10

Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection.

Ofotokun I, Titanji K, Vunnava A, Roser-Page S, Vikulina T, Villinger F, Rogers K, Sheth AN, Lahiri CD, Lennox JL, Weitzmann MN. Ofotokun I, et al. Among authors: sheth an. AIDS. 2016 Jan 28;30(3):405-14. doi: 10.1097/QAD.0000000000000918. AIDS. 2016. PMID: 26760232 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters